PA
HGEN

Pinnacle Associates’s HUMANIGEN, INC. HGEN Stock Holding History

Pinnacle Associates’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,500
Closed -$2K – 778
2022
Q3 		$2K Hold
12,500
– – ﹤0.01% 739
2022
Q2 		$22K Hold
12,500
– – ﹤0.01% 742
2022
Q1 		$38K Buy
12,500
+2,000
+19% +$5.35K ﹤0.01% 782
2021
Q4 		$39K Buy
+10,500
New +$61.4K ﹤0.01% 788

Other funds holding HGEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pinnacle Associates's HGEN Position: Q4 2022 in Review

Pinnacle Associates sold out of HUMANIGEN, INC. (HGEN) in Q4 2022, closing a stake of 12,500 shares — an estimated $2K sold.

Pinnacle Associates first reported a position in HGEN in Q4 2021 and held it in 4 quarters. The position peaked at $39K in Q4 2021. 48 funds tracked by Wall St. Rank hold HGEN as of Q4 2022.

  • Pinnacle Associates reported no remaining HUMANIGEN, INC. position as of Q4 2022 after selling out during the quarter.
  • Pinnacle Associates sold 12,500 HUMANIGEN, INC. shares in Q4 2022, an estimated $2K.
  • Pinnacle Associates first reported a position in HUMANIGEN, INC. in Q4 2021 and held it in 4 quarters.
  • Pinnacle Associates's HUMANIGEN, INC. position peaked at $39K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2022.

Based on Pinnacle Associates's 13F filing for Q4 2022, filed 25 Jan 2023.